Novartis AG
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people's lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach nearly 300 million people worldwide.
Profit margin of 23.9% — that's well above average.
Current Price
$146.57
-0.87%GoodMoat Value
$194.53
32.7% undervaluedNovartis AG (NVS) Insider Trades
NVS Insider Trading Activity
Track insider trading transactions for Novartis AG (NVS). Monitor recent buys, sells, and option exercises by officers, directors, and 10% beneficial owners. Insider trading activity can signal management confidence or concern about a stock's future prospects.
Current stock price: $146.57. Market cap: $279.68B. This page displays the most recent insider transactions for NVS, including the insider's name, title, transaction type (purchase, sale, or option exercise), number of shares, and total value. Filter transactions by type to focus on open-market purchases or sales.
Insider buying is often viewed as a bullish signal, as insiders are putting their own capital at risk. Conversely, large insider sales may warrant further investigation. Use GoodMoat's insider trading data alongside financial analysis, quality scores, and valuation tools for a comprehensive view of Novartis AG's investment outlook.